High expression of CD11c indicates favorable prognosis in patients with gastric cancer

Table 2 Baseline characteristics of the low and high CD11c expression groups (n = 140)

Clinicopathological characteristics	All		CD11c expression				P value
			Low		High
	No.	%	No.	%	No.	%
Gender							0.113
Male	107	76.43	80	73.39	27	87.10
Female	33	23.57	29	26.61	4	12.90
Age (yr)							0.162
About 45	12	8.57	9	8.26	3	9.68
About 60	66	47.14	56	51.38	10	32.26
> 60	62	44.29	44	40.37	18	58.06
Tumor location
Gastric cardia							0.342
No	87	62.14	70	64.22	17	54.84
Yes	53	37.86	39	35.78	14	45.16
Tumor size (cm)1							< 0.001
< 5	56	47.46	36	38.71	20	80.00
≥ 5	62	52.54	57	61.29	5	20.00
Histological type2							0.042
Differentiated	54	40.60	37	35.92	17	56.67
Poorly differentiated	79	59.40	66	64.08	13	43.33
Invasion to muscular layer3							0.004
No	14	11.57	7	7.29	7	28.00
Yes	107	88.43	89	92.71	18	72.00
Nodal metastasis4							0.001
No	33	27.27	19	20.00	14	53.85
Yes	88	72.73	76	80.00	12	46.15
Pathological grade							0.047
1-2	17	12.14	13	11.93	4	12.90
3	70	50.00	49	44.95	21	67.74
4	53	37.86	47	43.12	6	19.35
UICC stage							0.002
I	11	7.86	4	3.67	7	22.58
II	27	19.29	22	20.18	5	16.13
III	88	62.86	69	63.30	19	61.29
IV	14	10.00	14	12.84	0	0.00
Endpoint: DFS							0.038
No recurrence	20	14.29	12	11.01	8	25.81
Recurrence	120	85.71	97	88.99	23	74.19
Endpoint: OS							0.404
Survival	37	26.43	27	24.77	10	32.26
Died	103	73.57	82	75.23	21	67.74

¹Missing 22 cases;

²Missing 7 cases;

³Missing 19 cases;

⁴Missing 19 cases.